NFL: Report: Saints sign Justin March-Lillard, Ethan Westbrooks for Monday

Date:

Share post:


Looking to reinforce their COVID-19-depleted roster, the New Orleans Saints reportedly signed linebacker Justin March-Lillard and defensive tackle Ethan Westbrooks ahead of Monday night’s home matchup vs. the Miami Dolphins.

According to Nola.com, the two veteran defenders flew to New Orleans on Sunday evening and were expected to join the team Monday morning. They’ll play on Monday night pending negative COVID-19 tests.

March-Lillard, 28, appeared in one game on special teams for the San Francisco 49ers in December. He joined the league in 2016 with the Kansas City Chiefs and spent the previous four seasons with the Dallas Cowboys, where he played in 51 games overall with most of his playing time coming on special teams.

The 31-year-old Westbrooks, who played for five seasons with the St. Louis/Los Angeles Rams, hasn’t played in a regular season game since 2018. He did a short stint with the Las Vegas Raiders this past summer. He has 79 tackles and nine sacks in 67 career games (11 starts) for the Rams.

The Saints (7-7) currently have 15 active roster players on the reserve/COVID-19 list.

–Field Level Media

spot_img

Related articles

NFL: Jaguars QB Trevor Lawrence nixes trade rumors

Jaguars quarterback Trevor Lawrence said he plans to win a Super Bowl in Jacksonville, not Pittsburgh. Speaking for the...

NFL: Bengals sign P Ryan Rehkow to 2-year extension

The Cincinnati Bengals signed punter Ryan Rehkow to a two-year contract extension that spans through the 2026 season. The...

NFL: Reports: Bengals seek long-term deal for WR Tee Higgins, but could tag him

The Cincinnati Bengals are trying to work out a long-term contract with wide receiver Tee Higgins but are...

NFL: Report: Ravens OL Ben Cleveland facing DUI charge

Baltimore Ravens offensive lineman Ben Cleveland was arrested in Georgia last week for suspicion of drunk driving, TMZ...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.